ArticleNeuropharmacology2012

TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.

S Edman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.